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ABSTRACT
We describe two elderly patients evaluated at emergency departments for anosmia/dysgeusia in the absence of any other respiratory 
symptoms prior to or upon admission. In the current epidemiological context, clinical and biological work-up led to a diagnosis of COVID-19 
infection. Unfortunately, one of the patients died during hospitalization, but the other recovered and was discharged. 
LEARNING POINTS
• In the current epidemiological situation, anosmia and dysgeusia in the absence of other respiratory conditions should be carefully 
evaluated. 
• Special attention should be given to patients with non-classic COVID-19 symptoms in order to reduce transmission and protect health 
providers
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INTRODUCTION
The Coronaviruses are a large family of viruses which cause illnesses ranging from the common cold to more severe disease. SARS-CoV-2 
is a novel Coronavirus which was first detected in China and is now spreading globally[1]. The beginning of the COVID-19 outbreak was 
associated with a seafood market selling live animals which most patients had attended. However, with progression of the outbreak, the 
illness is now spread by person-to-person transmission. The common serious manifestation of COVID-19 infection is pneumonia.
CASE DESCRIPTION
Case 1
An 85-year-old man was admitted to the emergency department for a 4-day history of sudden anosmia and fatigue without any history 
of fever, cough or shortness of breath. He had previously refused to visit his primary care doctor. His medical history was relevant for 
hypertension, ischaemic heart disease and type 2 diabetes. He lived with his wife and there was apparently no close contact with anybody 
with acute respiratory symptoms. Upon admission, the patient was afebrile, his blood pressure was 110/80 mmHg, heart rate was 82 bmp 
and oxygen saturation was 94% on room air. On physical examination, he was alert but asthenic. 
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Heart sounds were regular without murmurs, but vesicular breath sounds were bilaterally decreased in both pulmonary bases on 
auscultation. Blood tests showed elevated C-reactive protein (210 mg/l), lymphopenia and thrombopenia (88×109/l). Electrolytes and liver 
function tests were within normal ranges and the glomerular filtration rate (GFR) was 65 ml/min. D-dimer was elevated (3,500 ng/ml). A 
thoracic angiogram was normal. PCR for SARS-CoV-2 came back positive, confirming the diagnosis of COVID-19. The patient was treated 
in a normal hospital bed. Three days after hospital admission (6 days after symptom onset), the patient developed acute respiratory distress 
syndrome (ARDS) and died. 
Case 2
An 80-year-old woman was admitted to the emergency department for a 5-day history of taste loss preceding smelling problems and 
fatigue. The was no history of fever, chills or dyspnoea before her admission. Her medical history was relevant for hypertension, heart 
failure and end-stage chronic renal disease. She lives with her daughter who works in a nursing home and is apparently in good health. Upon 
admission, the patient was febrile (38.1°C), and had a blood pressure of 100/50 mmHg, heart rate of 90 bmp and oxygen saturation of 92% 
on room air. On physical examination, she was alert and oriented to time, space and person. Heart sounds were regular without murmurs 
but the vesicular breath sounds were decreased in the right pulmonary base on auscultation. Blood tests showed leucocytosis (12.6×109/l) 
with a predominance of polynuclear neutrophils (11.72×109/l) but normal lymphocyte and platelet counts. Electrolytes, liver, renal and 
coagulation tests were within normal ranges. The chest CT demonstrated the presence of ground-glass opacification in the right lower lobe. 
The investigations were completed with PCR for SARS-CoV-2 which confirmed the diagnosis of COVID-19. The patient was hospitalized in 
a normal hospital bed. Asymptomatic treatment and an oxygen supply were initiated. The clinical course was marked by the absence of any 
clinical or biological complications and the patient was discharged 14 days after hospital admission.
DISCUSSION
There are no specific clinical symptoms which allow COVID-19 to be reliably distinguished from other types of viral respiratory infection. 
Symptomatic infection ranges from mild to critical, but most infections are not severe. However, some patients with initially mild symptoms 
may progress to more severe symptoms over the course of a week [2].
Pneumonia evolving to ARDS is the major complication in patients with severe disease and can develop shortly after the onset of dyspnoea. 
Other reported complications included arrhythmias, acute cardiac injury and shock. Pneumonia is usually accompanied by fever, cough, 
fatigue, anorexia and myalgia. Of note, fever might not be a universal finding according a Chinese study which reported it could be initially 
absent or appear during the course of the disease [3]. Another study reported lack of respiratory symptoms such as coughing and sputum 
production but the presence of gastrointestinal symptoms such as nausea, vomiting and diarrhoea in patients positive for COVID-19 [4].
Other Coronaviruses have been associated with anosmia, so it is not surprising that anosmia has been anecdotally reported as a 
distinguishing symptom in patients ultimately diagnosed with COVID-19. However, available cohort studies have not highlighted this 
symptom, and its frequency and utility in suspecting COVID-19 is still uncertain [5, 6]. Anosmia has particularly been seen in patients positive 
for the Coronavirus with no other clinical features. It is been suggested that the virus causes some sort of inflammation in the olfactory 
nerves rather than damage to the structure of the receptors.
The olfactory system is designed to survive the constant bombardment of pathogens, so any dysfunction will only be temporary. While 
the olfactory nerve cells within the nasal lining can be infected and die, stem cells rapidly generate new nerve cells which extend their long 
connections back up into the brain to restore the pathway. Depending on the severity of the initial infection, the sense of smell can return 
within a few days or weeks. Patients with taste loss actually have an impaired sense of smell, which has a huge impact on their ability to 
detect flavour. Smell and taste both contribute to perception of flavour, making difficult for patients to separate the two senses.
CONCLUSIONS
Anosmia, hyposmia and dysgeusia in the absence of other respiratory diseases such as allergic rhinitis, acute rhinosinusitis or chronic 
rhinosinusitis, should alert physicians to the possibility of COVID-19 infection and prompt serious consideration of self-isolation and 
testing of these individuals. In an effort to establish the true significance of these symptoms in the diagnosis and progression of COVID-19, 
the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) has issued their ‘COVID-19 Anosmia Reporting Tool for 
Clinicians’ [5]. 
Anosmia and dysgeusia should prompt COVID-19 infection screening even in the absence of classic respiratory symptoms in the present 
epidemiological context.
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